PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30324757-10	2019	Histopathology examinations showed the ranking of irritations (from slight to severe) were PHT-loaded rh-insulin, negative air control and PS-loaded rh-insulin.	Rhodium	102-104	insulin	Homo sapiens	105-112	
16715386-7	2006	The difference in degradation rate between the insulin-dextran and insulin-trehalose systems observed at 12% RH was eliminated at 43% RH.	Rhodium	109-111	insulin	Homo sapiens	47-54	
16715386-7	2006	The difference in degradation rate between the insulin-dextran and insulin-trehalose systems observed at 12% RH was eliminated at 43% RH.	Rhodium	109-111	insulin	Homo sapiens	67-74	
16715386-7	2006	The difference in degradation rate between the insulin-dextran and insulin-trehalose systems observed at 12% RH was eliminated at 43% RH.	Rhodium	134-136	insulin	Homo sapiens	47-54	
16715386-7	2006	The difference in degradation rate between the insulin-dextran and insulin-trehalose systems observed at 12% RH was eliminated at 43% RH.	Rhodium	134-136	insulin	Homo sapiens	67-74	
16715386-8	2006	In addition, the T1rho of the insulin carbonyl carbon at low humidity (12% RH) was prolonged by the addition of trehalose, but not by the addition of dextran.	Rhodium	75-77	insulin	Homo sapiens	30-37	
16078146-6	2005	The temperature- and Tg-dependence of the degradation rate indicated that the reactivity of insulin in the trehalose formulation is affected by molecular mobility at low humidity (12% RH), such that the ratio of the observed rate constant (k") to the rate constant governed only by the activational barrier (k) was 0.051 at the Tg.	Rhodium	184-186	insulin	Homo sapiens	92-99	
30324757-11	2019	CONCLUSIONS: Both PS- and PHT-loaded rh-insulin dry powders were able to deliver rh-insulin systemically with appropriate pharmacokinetic, pharmacodynamic and safety profiles.	Rhodium	37-39	insulin	Homo sapiens	40-47